Cutting-Edge Advances in Breast Cancer

Dear Colleague,

Breast cancer remains a significant global health challenge, but recent advancements in research and treatment have dramatically improved outcomes for many patients. This Special Issue will explore cutting-edge innovations that are transforming breast cancer care, including the following:  

• Precision medicine: Tailoring treatment based on individual tumour characteristics, such as genetic mutations and molecular subtypes, is revolutionizing breast cancer care.  
• Immunotherapy: Harnessing the power of the immune system to fight cancer, including checkpoint inhibitors and immune cell therapies, offers promising new avenues for treatment.  
• Targeted therapies: These drugs specifically target cancer cells and their supporting pathways, minimizing harm to healthy tissues.  
• Early detection and screening: Advances in imaging technologies and screening techniques are improving early detection and enabling earlier, more effective treatment.  
• Personalized medicine: Integrating patient preferences, lifestyle factors, and social determinants of health into treatment plans is crucial in improving overall patient outcomes.  

For this Special Issue, we invite papers sharing new basic and translational research findings, clinical trials, and emerging technologies that are shaping the future of breast cancer care and offer hope for improved survival and quality of life for patients.

Dr. Ľuba Hunáková
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.